For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
NYS Entity Status
NYS Filing Date
SEPTEMBER 06, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - AMPHORA PARTNERS, LLC
AROUND THE WEB
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
- The Link Between Huntington’s Disease and Brain Structure
Wednesday Sep 6, 2017
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These finding may explain the causes of the debilitating symptoms and loss of brain tissue as the disease progresses. Currently, it is not understood why the mutation of a specific gene leads to expression of symptoms and loss -
- Rooted in Counterculture, Whole Foods’ Founder Finds an Unlikely Refuge
By MICHAEL J. de la MERCED and ALEXANDRA STEVENSON - Friday Jun 16, 2017
John Mackey wanted to fight off the activist investors attacking Whole Foods. He found a savior in Amazon, a company blamed for laying waste to retailers.
- Third Point, a Hedge Fund, Sets Its Activist Sights on Nestlé
By MICHAEL J. de la MERCED - Sunday Jun 25, 2017
The fund, run by Daniel S. Loeb, has called on the Swiss food giant to sell its stake in L’Oréal and move more quickly to adapt to changing consumer tastes.